ANISA ORTIZ: Open Payments
NPI 1427642537 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 17 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $522 |
| Braeburn Inc. | 3 | $239 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| Vanda Pharmaceuticals Inc. | 1 | $99 |
Products named: VRAYLAR, BRIXADI, AUSTEDO XR, CAPLYTA, REXULTI, FANAPT.
Industry payments across PA — which companies pay providers there.
